PRAGUE

PRAGUE
IPFA/PEI 22nd International Workshop on
“Surveillance and Screening of Blood Borne Pathogens”
In collaboration with the Czech Society for Transfusion Medicine
20-21 May 2015
Corinthia Hotel Prague, Prague, Czech Republic
The International Plasma Fractionation Association (IPFA)
and the Paul-Ehrlich-Institut (PEI) are pleased to announce
the 22nd annual International Workshop on “Surveillance
and Screening of Blood Borne Pathogens”. The Workshop will
be held in Prague on 20-21 May 2015 at the Corinthia Hotel
Prague and will be hosted by the Czech Society for Transfusion
Medicine.
Range of topics
This annual International Workshop will, as usual, address key
issues concerning the availability, regulation and risk benefit of
existing and potential new developments, designed to ensure
the microbiological safety of blood components and plasma
derivatives. The event will build on IPFA’s traditions of open and
inclusive discussions between all stakeholders who may have an
interest in and/or responsibility for maintaining a safe and secure
supply of blood components and plasma products.
Who should attend?
The workshop has evolved to become a highly regarded
international event, regularly attracting contributions from
recognized international experts and opinion formers and
delegates from more than 30 countries from all regions of the
world.
Event details | Registration | Sponsorship
For event details, registration and sponsorship
opportunities please visit www.ipfa.nl.
You may also contact the IPFA Secretariat for further
information: [email protected]; tel. +31 20 512 35 61.
We warmly invite you to attend this meeting and look forward
to welcoming you to Prague for what we expect to be another
informative and productive Workshop!
Dr Paul Strengers, President IPFA
Dr Micha Nübling, Head Molecular Virology PEI
Dr Vit Rehacek, President Czech Society for Transfusion
Medicine
Dr Petr Turek, Head National Transfusion Committee of MoH
The workshop will be of interest to:
• Blood establishments
• Doctors and health care providers
• Industry
• Regulatory authorities
• Patient organisations
• Academia